Search results
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 1 day agoUSA News Group – An alarming trend is happening around the world, where tens of millions of...
Vaccine breakthrough means no more chasing strains
UC Newsroom· 7 days agoEvery year, researchers try to predict the four influenza strains that are most likely to be prevalent during the upcoming flu season. The same is true of COVID vaccines, ...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 5 days agoMost individuals who wanted a vaccine last year will probably get another this year. Pfizer hopes to...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 2 days agos revenue in 2023 fell 42% from the previous year. Sales for the company's top-selling product,...
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Motley Fool via Yahoo Finance· 4 days agoBlame it mainly on declining demand for the company's COVID-19 vaccine and oral antiviral drug...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 1 day agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Sagaliam Acquisition Corp Launches Improved IPF Formula with Vitamin C in Pill and Lozenge Form and...
Digital Journal· 1 day agoVirogentics, a subsidiary of Sagaliam, is advancing multiple therapeutics targeting numerous infectious diseases. One patented and clinically tested compound, ITV-1 (Immune ...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 4 days agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 7 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision...
WFRV 5 Green Bay· 2 days agoInfinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating ...